Esperion therapeutics, inc. (ESPR)
CashFlow / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14
Operating activities
Net income (loss)

-262,793

-97,165

-95,258

-76,792

-68,301

-201,810

-179,662

-174,970

-172,577

-166,988

-158,053

-130,236

-100,934

-74,978

-59,144

-54,543

-52,903

-49,784

-46,119

-43,124

-39,967

-36,375

0

0

0

Adjustments to reconcile net income (loss) to net cash used in operating activities:
Depreciation expense

335

300

327

302

310

300

295

290

292

300

258

259

257

252

257

248

241

236

225

222

207

160

0

0

0

Amortization of debt discount

-

-

-

-

-

-

-

-

-

-

-

-

-

-

24

26

27

29

0

0

0

-

-

-

-

Amortization of debt issuance costs

-

-

-

-

-

-

-

-

-

-

-

-

-

-

26

29

31

32

0

0

0

-

-

-

-

Accretion of premiums and discounts on investments

198

200

0

0

0

-

-

-

-

-334

-562

-773

-908

-1,014

-1,017

-961

-874

-647

-438

-274

-176

-202

0

0

0

Non-cash interest expense related to the revenue interest liability

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Stock-based compensation expense

26,301

25,884

26,355

25,523

24,683

23,968

21,673

21,119

20,376

18,605

17,642

16,410

15,551

15,957

16,771

16,433

15,210

12,726

9,394

6,973

5,010

3,679

0

0

0

Loss related to assets held for sale

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-29

0

0

0

Loss on sale of assets

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-2

0

0

0

Changes in assets and liabilities:
Prepaids and other assets

7,228

3,396

-581

-3,941

1,169

2,884

5,540

5,170

-1,983

1,731

86

1,630

3,545

-139

117

979

866

1,275

1,639

-655

96

264

0

0

0

Deferred revenue

-3,411

2,152

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Inventories

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accounts payable

-18,156

-16,055

5,096

5,634

21,310

24,446

-956

3,746

307

15,758

17,718

17,148

10,093

3,888

-177

-1,739

-1,313

-1,333

-1,430

-823

673

-299

0

0

0

Other accrued liabilities

23,302

10,000

7,504

9,572

5,187

7,594

9,526

1,824

9,268

2,462

9,250

6,137

5,440

5,998

1,430

2,128

-44

519

1,157

1,044

1,756

814

0

0

0

Net cash (used in) provided by operating activities

-231,379

-70,341

-49,039

-28,537

-13,726

-148,638

-154,820

-153,177

-140,207

-131,302

-112,744

-91,164

-72,243

-47,730

-39,863

-37,389

-38,696

-38,156

-37,915

-34,716

-32,180

-32,021

0

0

0

Purchases of investments

0

-

-

-

-

25,481

32,085

203,348

206,006

219,577

246,677

121,377

155,169

197,230

201,890

225,047

280,457

280,559

285,483

211,422

115,442

48,088

0

0

0

Proceeds from sales/maturities of investments

84,825

99,510

133,183

156,523

167,063

166,081

182,411

186,077

184,273

183,743

170,285

185,578

211,525

207,442

209,819

182,720

148,269

120,792

81,295

45,420

20,738

12,351

0

0

0

Purchase of property and equipment

955

953

0

0

0

-

-

-

-

19

0

0

0

-

-

-

-

325

117

256

607

873

0

0

0

Net cash provided by investing activities

45,124

64,231

105,667

151,008

155,862

140,449

150,280

-17,271

-21,738

-35,853

-76,500

64,093

56,248

10,118

7,711

-42,618

-132,482

-160,068

-204,296

-166,252

-95,299

-36,598

0

0

0

Financing activities
Proceeds from issuance of common stock, net of issuance costs

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

189,983

0

0

0

-

-

-

-

Proceeds from exercise of common stock options

11,116

11,771

5,099

3,925

3,674

11,743

11,836

12,219

10,638

1,167

732

332

285

45

45

414

940

1,177

1,343

1,129

685

473

0

0

0

Payments on long-term debt

-

-

-

-

-

1,049

1,486

1,764

1,737

1,709

1,683

1,656

1,630

1,604

0

0

0

-

-

-

-

-

-

-

-

Net cash provided by financing activities

160,540

136,195

129,523

128,421

3,070

10,694

10,271

174,455

172,901

163,458

163,128

-1,324

-1,345

-1,559

-1,532

-1,012

-256

190,522

282,803

282,811

287,482

97,120

0

0

0

Net increase (decrease) in cash and cash equivalents

-25,715

130,085

186,151

250,892

145,206

2,505

5,731

4,007

10,956

-3,697

-26,116

-28,395

-17,340

-39,171

-33,684

-81,019

-171,434

-7,702

40,592

81,843

160,003

28,501

0

0

0

Supplemental disclosure of cash flow information:
Purchase of property and equipment not yet paid

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Non cash right of use asset

97

31

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Offering costs not yet paid

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-